Siri Purnima Yalamanchili is a Akron, Ohio based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Siri Purnima Yalamanchili is 35150134 for Ophthalmology in Ohio. Siri Purnima Yalamanchili is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Siri Purnima Yalamanchili speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Female
Practice Address:
525 E Market St, Akron, Ohio, 44304-1619
Phone:
330-375-3315
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1134757065
NPI Enumeration Date:
27 Mar, 2020
NPI Last Update On:
26 Jun, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Siri Purnima Yalamanchili are as mentioned below.
License Number
Specialization
State
Status
35150134
Ophthalmology
Ohio
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
36177 N Park Dr, Avon, Ohio
Zip:
44011-3444
Phone Number:
--
Fax Number:
--
Patients can reach Siri Purnima Yalamanchili at 525 E Market St, Akron, Ohio or can call to book an appointment on 330-375-3315. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.